ARS Pharmaceuticals, Inc. (SPRY)

SEC filing

ARS Pharmaceuticals, Inc.

SPRY · CIK 1671858

4 · Nov 14, 2025 · Chakma Justin sold 166.38K shares at $8.87/share ($1.5M); exercised options for 30K shares

Chakma Justin sold 166.38K shares at $8.87/share ($1.5M); exercised options for 30K shares

xslF345X05/form4-11142025_111150.xml

xslF345X05/form4-11142025_111150.xmlSEC.gov

Graphics and non-inline formats (not embedded below).